医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2015年
2期
70-70,71
,共2页
低分子肝素%脑络通%脑梗塞%疗效观察
低分子肝素%腦絡通%腦梗塞%療效觀察
저분자간소%뇌락통%뇌경새%료효관찰
Low molecular heparin%The brain. Cerebral infarction%Clinical observation on
目的：评估脑络通与低分子肝素联合治疗脑梗塞的临床疗效。方法：按就诊顺序将患者分为实验组与对照组，实验组36例给予低分子肝素、脑络通；对照组给予丹参或低分子右旋糖酐。根据爱丁堡—斯堪的那维亚改良评分（0～45分），对神经功能缺损积分进行比较。结果：两组治疗效果比较有显著差异（P<0.05）。结论：低分子肝素与脑络通联合治疗脑梗塞，疗效好，使用方便。
目的：評估腦絡通與低分子肝素聯閤治療腦梗塞的臨床療效。方法：按就診順序將患者分為實驗組與對照組，實驗組36例給予低分子肝素、腦絡通；對照組給予丹參或低分子右鏇糖酐。根據愛丁堡—斯堪的那維亞改良評分（0～45分），對神經功能缺損積分進行比較。結果：兩組治療效果比較有顯著差異（P<0.05）。結論：低分子肝素與腦絡通聯閤治療腦梗塞，療效好，使用方便。
목적：평고뇌락통여저분자간소연합치료뇌경새적림상료효。방법：안취진순서장환자분위실험조여대조조，실험조36례급여저분자간소、뇌락통；대조조급여단삼혹저분자우선당항。근거애정보—사감적나유아개량평분（0～45분），대신경공능결손적분진행비교。결과：량조치료효과비교유현저차이（P<0.05）。결론：저분자간소여뇌락통연합치료뇌경새，료효호，사용방편。
Objective To evaluate the brain with low molecular heparin combined clinical curative effect for the treatment of cerebral infarction.Methods According to the order will be patients candidate for experimental group and control group, experimental group 36 cases to low molecular heparin, the brain; The control group to salvia miltiorrhiza or low molecular dextran. According to the Edinburgh - Scandinavian improved score (0-45, the nerve function defect integral is used in the comparison.Results Two groups of treatment effect is more significant difference (P < 0.05).Conclusions Low molecular heparin and brain collaterals combined treatment of cerebral infarction, curative effect is good, easy to use.
